scispace - formally typeset
Open AccessJournal ArticleDOI

Excitement Reduces Inhibition via Endocannabinoids

Tamás F. Freund, +1 more
- 08 May 2003 - 
- Vol. 38, Iss: 3, pp 362-365
Reads0
Chats0
TLDR
This issue of Neuron provides evidence for another form of endocannabinoid-mediated depression of hippocampal inhibition, which is activity dependent and long lasting.
About
This article is published in Neuron.The article was published on 2003-05-08 and is currently open access. It has received 39 citations till now. The article focuses on the topics: Synaptic signaling.

read more

Citations
More filters
Journal ArticleDOI

The endocannabinoid system in brain reward processes

TL;DR: The influence of the endocannabinoid system on brain reward processes may depend on the degree of activation of the different brain areas involved and might represent a mechanism for fine‐tuning dopaminergic activity.
Journal ArticleDOI

Sleep and movement differentiates actions of two types of somatostatin-expressing GABAergic interneuron in rat hippocampus.

TL;DR: It is shown that behavioral and network states differentiate the activities of bistratified and O-LM cells in freely moving rats, and peptide/GABA-releasing interneurons' firing patterns during behavior are unknown.
Journal ArticleDOI

Pharmacological treatments that facilitate extinction of fear: relevance to psychotherapy.

TL;DR: It is concluded that extinction is an excellent model system for the study of fear inhibition and an indispensable tool for the screening of putative pharmacotherapies for clinical use.
Journal ArticleDOI

Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain.

TL;DR: The levels of the two major endocannabinoids, anandamide and 2-arachidonoyl-glycerol (2-AG), in four areas of the rat brain, change dramatically between the light and dark phases of the day, suggesting that the levels might be under the control of endogenous factors known to undergo diurnal variations.
Journal ArticleDOI

A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders.

TL;DR: Cannabinoid receptors in the CNS have been implicated in the control of appetite, cognition, mood and drug dependence and CB1 receptor antagonism might constitute an integrated pharmacotherapeutic approach that impacts the affective, cognitive, appetitive and motivational neuronal networks involved in mood disorders.
References
More filters
Journal ArticleDOI

The endogenous cannabinoid system controls extinction of aversive memories

TL;DR: Treatment of wild-type mice with the CB1 antagonist SR141716A mimicked the phenotype of CB1-deficient mice, revealing that CB1 is required at the moment of memory extinction, and proposes that endocannabinoids facilitate extinction of aversive memories through their selective inhibitory effects on local inhibitory networks in the amygdala.
Journal ArticleDOI

Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses.

TL;DR: The transient suppression of GABA-mediated transmission that follows depolarization of hippocampal pyramidal neurons is mediated by retrograde signalling through release of endogenous cannabinoids, indicating that the function of endogenous cannabinoid released by depolarized hippocampal neurons might be to downregulate GABA release.
Journal ArticleDOI

Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons

TL;DR: The results suggest that cannabinoid-mediated modulation of hippocampal interneuron networks operate largely via presynaptic receptors on CCK-immunoreactive basket cell terminals, the likely mechanism by which both endogenous and exogenous CB1 ligands interfere with hippocampal network oscillations and associated cognitive functions.
Journal ArticleDOI

Total number and distribution of inhibitory and excitatory synapses on hippocampal CA1 pyramidal cells

TL;DR: The results indicate that the highly convergent excitation arriving onto the distal dendrites of pyramidal cells is primarily controlled by proximally located inhibition and the organization of excitatory and inhibitory inputs in layers receiving Schaffer collateral input (radiatum/oriens) versus perforant path input (lacunosum-moleculare) is significantly different.
Journal ArticleDOI

Retrograde Inhibition of Presynaptic Calcium Influx by Endogenous Cannabinoids at Excitatory Synapses onto Purkinje Cells

TL;DR: It is suggested that Purkinje cells release endogenous cannabinoids in response to elevated calcium, thereby inhibiting presynaptic calcium entry and suppressing transmitter release, and suggesting a widespread role for endogenous cannabinoid in retrograde synaptic inhibition.
Related Papers (5)